Dimerization-driven activation of the intracellular kinase domains of the epidermal growth factor receptor (EGFR) upon extracellular ligand binding is crucial to cellular pathways regulating proliferation, migration, and differentiation. Inactive EGFR can exist as both monomers and dimers, suggesting that the mechanism regulating EGFR activity may be subtle. The membrane itself may play a role but creates substantial difficulties for structural studies. Our molecular dynamics simulations of membraneembedded EGFR suggest that, in ligand-bound dimers, the extracellular domains assume conformations favoring dimerization of the transmembrane helices near their N termini, dimerization of the juxtamembrane segments, and formation of asymmetric (active) kinase dimers. In ligand-free dimers, by holding apart the N termini of the transmembrane helices, the extracellular domains instead favor C-terminal dimerization of the transmembrane helices, juxtamembrane segment dissociation and membrane burial, and formation of symmetric (inactive) kinase dimers. Electrostatic interactions of EGFR's intracellular module with the membrane are critical in maintaining this coupling.
INTRODUCTION
The epidermal growth factor receptor (EGFR, or Her1/ErbB1) is one of the four members of the Her (ErbB) family of receptor tyrosine kinases, which also includes Her2 (ErbB2/Neu), Her3 (ErbB3), and Her4 (ErbB4). These proteins serve as cell-surface receptors for the peptide ligands of the epidermal growth factor (EGF) family and play crucial roles in regulating cell proliferation, migration, and differentiation (Citri and Yarden, 2006) ; their aberrant activity is implicated in a variety of cancers (Riese et al., 2007) . Consequently, Her proteins, and EGFR and Her2 in particular, are among the most intensely pursued drug targets.
The EGF receptor consists of an extracellular module (comprising domains I, II, III, and IV) and an intracellular kinase domain (with a long regulatory C-terminal tail), which are connected by a single-helix transmembrane segment and a juxtamembrane segment (Figure 1 ). EGFR activation is dimerization dependent (Schlessinger, 2002) . Ligand binding elicits a ''backto-back'' dimer of the extracellular domains (Ogiso et al., 2002; Garrett et al., 2002) , which leads the intracellular kinase domains to form enzymatically active (asymmetric) dimers (Zhang et al., 2006) . Crystal structures of monomeric extracellular domains (Ferguson et al., 2003) and of an inactive, symmetric kinase dimer (Jura et al., 2009 ) have also been resolved. At low resolution, detergent-solubilized dimers of nearly full-length receptors have been visualized (Mi et al., 2011) . A number of studies (e.g., Low-Nam et al., 2011; Chung et al., 2010; Clayton et al., 2005) have shown that EGFR can also exist as preformed dimers in the absence of ligands.
A body of experimental evidence shows that the EGFR components that promote the dimerization and activation of the receptors are intertwined with the components that inhibit these processes (Figure 1 ). Although isolated kinase domains are predominantly monomeric in solution (Zhang et al., 2006) , they dimerize and activate strongly when the juxtamembrane segments are included (Jura et al., 2009 ). When such EGFR constructs are localized to cell membranes, however, their activities are abrogated. This surprising finding is reported in this issue of Cell in the accompanying paper by Endres et al. (2013) , which also shows that the activity may be recovered by the addition of the transmembrane segments and abrogated at low expression levels by the further addition of the extracellular domains. These findings suggest that the transmembrane and juxtamembrane segments on balance favor EGFR activation, whereas the kinase domain, the extracellular domains, and the EGFR interaction with the cell membrane contribute to EGFR autoinhibition. Although ligand binding enhances dimerization of the extracellular domains only modestly in solution (Odaka et al., 1997) , at the cell surface, it can tip the balance decisively toward activation.
The structural basis of these findings is uncertain, however, because the architecture of intact EGFR remains obscure. Various experiments have suggested the need to take the cell membranes into account (Bessman and Lemmon, 2012) , but this presents a formidable challenge to structural analysis. One key problem is the relatively poor understanding of the crucial middle sections of EGFR that are embedded in, or adjacent to, the cell membrane. It has been proposed that, in EGFR dimers, the transmembrane helices alternate between two dimer forms, one associated with inactive and the other with active EGFR dimers (Fleishman et al., 2002) , although direct evidence supporting this hypothesis is lacking. Although the juxtamembrane segments promote the dimerization and activation of EGFR kinases (Jura et al., 2009; Red Brewer et al., 2009) , the structural mechanism that couples the trans-and juxtamembrane segments is not understood.
The preformed dimers present another key problem. Although inactive EGFR is usually present as monomers in normal cells, at higher levels of expression, inactive, preformed dimers are commonly observed, and knowledge of their structure could shed light on the mechanisms by which EGFR activity is controlled. Their structure, however, remains unknown, although the observation that preformed dimers are primed for ligand binding (Chung et al., 2010) hints at a potentially close structural relationship to the active dimer in its extracellular domains. The existence of inactive dimers suggests a tight conformational coupling between the extra-and intracellular domains to prevent kinase activity in the absence of ligand, but puzzlingly, the dimerization of the extracellular domains and the dimerization of the intracellular kinase domains are not necessarily correlated, as shown by experiments on intact EGFRs in detergent micelles (Mi et al., 2011; Wang et al., 2011) . One possibility is that embedding EGFR in detergent micelles alters the receptor's behavior in important ways (Bessman and Lemmon, 2012) and that a structural understanding of signal transduction may need to take the membrane environment into account.
Here, we use molecular dynamics (MD) simulations to elucidate the overall architecture of EGFR and its interaction with the membrane to understand the cross-membrane coupling in these receptors. We adopted a divide-and-conquer strategy, initiating our model building with simulations of individual EGFR components in various contexts. Guided by observations from these simulations and by insights gained from coordinated experimental work described in the companion paper (Endres et al., 2013) , the components were then assembled into larger models, the simulations of which helped motivate further experimental work. We ultimately constructed and characterized nearly full-length models for the monomer, the ligand-free, inactive dimer, and the ligand-bound, active dimer. In simulations of the extracellular portion of a ligand-bound EGFR dimer, we found that the extracellular domains remained close to the (active) crystal structure but that this structure was no longer stable when the bound EGF ligands were removed. In particular, the two domain IVs underwent a conformational change that substantially increased the distance between their C termini. Because, in intact EGFR, the domain IVs are directly linked to the transmembrane domains, these extracellular domain simulations shed light on how ligand binding may be coupled to the arrangement of the transmembrane helices. Further simulations, together with nuclear magnetic resonance (NMR) and mutagenesis data (Endres et al., 2013) , demonstrated that the transmembrane helices may dimerize either near their N or C termini. The data further showed that antiparallel juxtamembrane helix dimers coexist with N-terminal transmembrane dimers but are incompatible with the C-terminal transmembrane dimers. Our simulations showed that, when the juxtamembrane dimers are disrupted, the juxtamembrane segments become embedded in the membrane. Consistent with earlier findings by Jura et al. (2009) , we show that a juxtamembrane helix dimer is compatible with the asymmetric kinase dimer and, hence, with EGFR activation. We find membrane-embedded juxtamembrane segments, on the other hand, to be compatible with both the symmetric kinase dimer and EGFR monomers and, thus, with EGFR autoinhibition. Combining these findings, we propose a structural mechanism that enables the receptors to relay signals across the membrane. Notably, the simulations indicate that membrane lipids, especially anionic lipids, interact extensively with the receptors and are integral to signal transduction. A detailed description of EGFR-membrane interaction from these simulations provides a mechanistic understanding of a dual role for anionic lipids in EGFR regulation in both inhibiting EGFR in the absence of ligand stimulus and in accentuating EGFR response to a stimulus.
RESULTS

Monomeric Extracellular Domains Are Conformationally Highly Flexible
In the ligand-bound extracellular EGFR dimer, each subunit binds one ligand between domains I and III and adopts an extended conformation (Figure 2 ; Garrett et al., 2002; Ogiso et al., 2002; Lu et al., 2010) . In the absence of ligands, monomeric extracellular domains may assume a ''tethered'' conformation (Cho and Leahy, 2002; Ferguson et al., 2003 ) that precludes dimerization. This conformation is characterized by a wide separation of domains I and III and the tether interaction between domain IV and the dimerization arm of domain II (Figure 2) . EGFR, however, can dimerize prior to EGF binding, suggesting that the extracellular domains in monomeric EGFR may adopt conformations other than tethered.
To investigate these conformations, we first simulated the monomer starting from the tethered conformation, in which, on a timescale of microseconds, the ''tether'' readily disengaged, but domains II and IV remained in extensive contact, shielding the dimerization arm ( Figure 2A ). Thus, our simulations suggest a limited role of the tether in EGFR autoinhibition, which is consistent with experimental findings (Mattoon et al., 2004; Dawson et al., 2007; Liu et al., 2012a) . Simulations of monomeric extracellular domains were also initiated from the extended conformation (both with and without EGF bound). These simulations demonstrated a significant conformational change occurring within 1-5 ms, in which the C terminus of the extracellular domains traveled a distance of $80 Å ( Figure 2B ). This happened largely as a result of the bending of domain IV around a ''hinge'' (residues 502-514), which produced a compact conformation of the extracellular domains not yet captured by crystallography, which resembled the extended conformation in domains I-III, and the tethered conformation in domain IV. The instability of the extended conformation for EGFR monomers confirms that the extracellular domains in monomers generally adopt compact conformations (Du et al., 2012) .
The Dimer Conformation of Ligand-free Extracellular Domains In contrast to the instability of the extended conformation of extracellular monomers, the extended conformation of the two subunits in a ligand-bound dimer (the ''two-ligand dimer'') remained stable in our simulations, which is consistent with the stabilizing effect of ligand binding to EGFR active dimers (B) Simulation of the extended monomeric extracellular module (one subunit taken from the ligand-bound extracellular dimer in PDB ID code 3NJP). Domain IV undergoes a large conformational change and reaches the dimerization arm of domain II, whereas domains I, II, and III largely remain stable. In both (A) and (B), the ''hinge'' in domain IV (residues 502-514) is highlighted in orange, and the starting conformations are shown in gray.
( Figure S1 available online). EGFR can also form ligand-free dimers that presumably need to be autoinhibited in normal cells. Because the crystal structure of the ligand-free extracellular dimer is not yet available for human EGFR, we attempted to investigate the structure using MD simulations. From the notion that the inactive dimers are primed for ligand binding (Chung et al., 2010; Sako et al., 2000) , we hypothesized that their extracellular domains bear structural resemblance to the active structure. We thus performed simulations based on the crystal structure of the two-ligand extracellular dimer. First, the crystal structure was simulated after one ligand was removed. In the simulation, the gap left by the removed ligand ( Figure 3 ) was filled by domains I and III, which came into contact with each other. The resultant conformation of the ligand-free subunit bears significant similarity in domains I-III ( Figure 3 ) to the ligandfree structures of Her2 Garrett et al., 2003) and Drosophila EGFR (Alvarado et al., , 2010 . Moreover, we observed a rotation of one subunit with respect to the dimerization arm of the other (Figures 3B and S1E), reflecting a transition between the ''staggered'' and the ''flush'' conformations (Liu et al., 2012b) . Perhaps more importantly, the rearrangement of domains I and III led to a ''bending'' motion at domain IV (Movie S1) around the hinge region in the ligand-free subunit of the ''oneligand dimer'' (where only one EGFR subunit is ligand bound), reminiscent of the ''bending'' in monomeric extracellular domains ( Figure 2B ). The bent domain IV was observed to occasionally return to its initial conformation ( Figure S1 ), likely reflecting a fluctuation between the two conformations in a one-ligand dimer. To further investigate the conformation of the ligand-free extracellular dimer, we removed the remaining ligand from the one-ligand extracellular dimer. Starting with a bent domain IV, subsequent simulations did not exhibit significant conformational changes, suggesting that a bent domain IV is stable in the absence of bound ligands in the dimer (Figures 3  and S1 ). The dimer is simulated starting from the crystal structure (PDB ID code 3NJP), retaining either both ligands (two-ligand dimer, left) or one ligand (one-ligand dimer, center). The final conformation of the one-ligand dimer simulation is used to initiate the simulation of the ligand-free dimer (right). The two domain IVs undergo a significant movement in the one-ligand dimer simulation, but not in the two-ligand or ligand-free dimer simulations. This results in a greater distance between the C termini (d CC ) in the one-ligand and ligand-free dimers than in the two-ligand dimer. (B) Side views of the dimer conformations. Transitions from the ''Staggered'' toward the ''Flush'' conformation (Liu et al., 2012b) are observed in our simulations of the one-ligand and ligand-free dimers. The dashed lines here indicate the principal axes of the domain IIs. See also Figure S1 and Movie S1.
Our results thus suggest that the removal of bound ligands results in significant rearrangement of the domain IVs. Instead of a V-shape arrangement of domain IVs in the two-ligand dimer, in the new arrangement, they adopt an antiparallel arrangement with a distance of $45 Å between the two C-terminal ends (d CC ), which is significantly greater than the distance in the two-ligand dimers (10 Å in crystal structures and $30 Å on average in our simulations; Figure S1E ). The distance d CC is important because, by altering it, the extracellular domains may communicate with the one-pass transmembrane helices and ultimately the cytoplasmic portion of the EGFR dimer. The basic observation concerning d CC was found to be robust to the choice of force field in our simulations (Supplemental Information).
The Transmembrane Helices Favor an N-Terminal Dimer
The transmembrane segment connects the extra-and intracellular domains. We expect that the transmembrane conformations in active and inactive EGFR dimers differ in ways that place substantial constraints on the possible structures of the intra-and extracellular modules. An EGFR transmembrane helix contains two GxxxG-like motifs (where the G represents a glycine or other small amino acid): one close to the N terminus (TGMVGA, residues 624-629, which itself comprises two overlapping GxxxG-like motifs) and the other to the C terminus (ALGIG, residues 637-641). Because GxxxG motifs often serve as dimerization interfaces of transmembrane helices (Lemmon et al., 1994; Russ and Engelman, 2000) , dimerization of the EGFR transmembrane helices at the N-or the C-terminal motifs has been suggested by Mendrola et al. (2002) and Fleishman et al. (2002) . Crosslinking experiments by Lu et al. (2010) confirmed that the ligand-bound active EGFR dimer contains dimer contacts at the N-terminal motif. The C-terminal transmembrane dimer, on the other hand, has been proposed to be part of the ligand-free inactive EGFR dimer (Landau and BenTal, 2008) .
To assess the relevance of these two potentially competing transmembrane-dimer forms for EGFR signaling, we investigated their stability using MD simulations. We constructed a model of the N-terminal transmembrane dimer using the resolved Her2 N-terminal dimer (Bocharov et al., 2008 ) as a template. The C-terminal dimer model was constructed so that the two helices were in contact at the C-terminal GxxxGlike motifs, and the angle between these two helices was similar to that in the Her2 N-terminal dimer. In a POPC/POPS lipid bilayer (see Supplemental Information), the N-terminal transmembrane dimer was found to be stable by itself, as it remained intact in simulations up to 100 ms long ( Figure 4A ), whereas the C-terminal dimer dissociated on a timescale of 100 ns to 10 ms ( Figure 4B) .
Consistent with the crosslinking experiments by Lu et al. (2010) , although the wild-type N-terminal dimer remained intact in simulations, the dimer interfaces were variable, including the GxxxG-like motif, as well as the adjacent residues. This is reflected in the distance between the interfacing residues, d int , which fluctuated around slightly different averages in the simulations, and in the varied residue contacts ( Figure 4A ).
The different stability of the N-and C-terminal transmembrane dimers may be in part attributed to the fact that the N-terminal dimerization interface is more extensive, consisting of two overlapping GxxxG-like motifs. Moreover, the glycine (Gly625) in the N-terminal motif is more favorable for dimerization than its counterpart (Ala637) at the C-terminal motif. Consistent with this observation, Her2 features glycines in its C-terminal motif (GVVFG, residues 646-650), and in our simulations, the C-terminal Her2 transmembrane dimer was stable for as long as 100 ms ( Figure S2 ).
The relative stability of the N-terminal EGFR transmembrane dimer was corroborated by further self-assembly simulations of the transmembrane helices initially placed distant from one other in a POPC/POPS lipid bilayer. In both such simulations, the transmembrane helices dimerized at the N-terminal GxxxG-like motifs, and resultant dimers remained stable throughout the simulations-50 ms or longer ( Figure 4D ).
The Model of the N-Terminal Transmembrane Dimer Is Consistent with NMR Measurements
From the nuclear Overhauser effect (NOE) spectroscopy of EGFR trans-and juxtamembrane segments (TM-JM) embedded in DMPC lipids, 21 pairs of adjacent residues from a TM-JM dimer (21 intersubunit ''NOEs,'' including 13 for the transmembrane and 8 for the juxtamembrane segments) were identified (Endres et al., 2013) . Almost all (up to 11 out of 13) of the transmembrane NOEs were satisfied in the aforementioned simulations of the N-terminal transmembrane dimer in POPC/POPS membrane bilayers, where the structural model was constructed independently from the NMR data, and the membrane lipids were different from those in the NMR experiments.
To further compare our model against the NMR data, we simulated the same system probed by the NMR experiments, where the transmembrane dimer was embedded in neutralcharged DMPC lipid bilayers with the juxtamembrane segments attached ( Figure 5 ). In the first of these simulations (''DMPC 1''), the initial conformation of the transmembrane dimer was taken from the last snapshot of the 100 ms simulation of the N-terminal transmembrane dimer in POPC/POPS lipids ( Figure 4A ), which satisfied 9 of the 13 transmembrane NOEs. The dimer reached a new conformation with a wider ($À70
) angle between the two helices 12 ms into the simulation ( Figure 5B ). Similarly, in simulation ''DMPC 4,'' an ensemble of conformations with angles ranging from À30 to À80 was observed. The alternative, ''narrow'' conformations also appeared to be accessible in DMPC, as the conformation remained stable in two other simulations (''DMPC 2'' and ''DMPC 3''). Each of these two sets of conformations satisfies up to 11 of the 13 transmembrane NOEs ( Figures 5A and S3) ; the wide conformations do not satisfy the two NOEs involving Val636, which are mostly satisfied in the narrow conformations ( Figures 5A and S3) .
Based on these observations, we suggest that an N-terminal transmembrane dimer exists in a dynamic equilibrium in DMPC bilayers. Indeed, we confirmed that an ensemble consisting of both the wide and the narrow transmembrane conformations can satisfy all of the 13 transmembrane NOEs (Figures 5A and  S3 ). It should be noted that the wide transmembrane-dimer conformations observed in the DMPC bilayers may not be viable in the thicker POPC/POPS bilayers or typical biological membranes. Transmembrane helices tend to be more tilted in thinner bilayers (Holt and Killian, 2010) , leading to larger interhelix angles in a dimer in the DMPC bilayers. It is noteworthy that simulated annealing, a standard method in NMR analysis, generated a model of a left-handed N-terminal transmembrane dimer. This model was unstable in simulations ( Figure S3 ) and is likely not adopted by EGFR. This indicates that the relatively small number of NOEs themselves may be insufficient to unambiguously distinguish different models.
The N-and the C-Terminal Transmembrane Dimers Represent an Active and an Inactive Conformation, Respectively The N-terminal transmembrane dimer is geometrically compatible with the two-ligand active extracellular dimer, in that the short distance between the N termini of the transmembrane helices matches that of the C termini of the two domain IVs in the active extracellular dimer. This is not the case for the C-terminal transmembrane dimer. We infer that the N-terminal transmembrane dimer is integral to an active EGFR dimer, a conclusion consistent with experiments by Lu et al. (2010) showing elevated levels of crosslinking at the N-terminal GxxxG-like motif upon EGF stimulus. The same study, however, also showed that mutations (T624L, G625L, G628L, and A629L) at the N-terminal motif do not disrupt EGFR activation, thus suggesting that N-terminal dimerization is not essential. We performed simulations of these mutants and found that the N-terminal transmembrane dimer in fact is resilient to these mutations ( Figure S2 ). (This observation is likely connected to the finding of Lu et al. (2010) that the N-terminal dimerization interface is structurally variable, a finding directly supported by our simulations, as discussed above.) The mutagenesis findings of Lu et al. (2010) thus are not necessarily inconsistent with an essential role for N-terminal dimerization of the transmembrane helices in EGFR activation. Additional support for this conclusion comes from investigations of the T624I/ G625I/G628I/A629I quadruple mutation, which impairs EGFR activation (Endres et al., 2013) ; our simulations of this mutant show that the N-terminal dimerization is indeed disrupted ( Figure S2 ).
The C-terminal transmembrane dimer has been hypothesized to be part of an inactive EGFR dimer (Fleishman et al., 2002; Landau and Ben-Tal, 2008) . Although our simulations suggest that the C-terminal dimers are relatively unstable on their own ( Figure 4B ), further simulations showed that they can be maintained if other EGFR components are present ( Figure S3D ). That the C-terminal transmembrane dimer matches the inferred structure of the ligand-free extracellular dimer is consistent with this hypothesis.
This hypothesis is further supported by the finding that an I640E mutation near the C-terminal GxxxG-like motif strongly inhibits EGFR activity in cells (Endres et al., 2013) . This mutation broke the N-terminal transmembrane dimer in simulation (Figure 4A) . The glutamate side chain tended to interact with lipid head groups rather than stay inside the membrane, reducing the effective hydrophobic length of the transmembrane helices, changing their orientation with respect to the membrane, and disrupting the dimer interface. This mechanism resembles that by which a similar transmembrane mutation of integrin b leads to the dissociation of its transmembrane domains and integrin activation . Moreover, glutamate side chains are known to form interchain hydrogen bonds in membranes (Sternberg and Gullick, 1989) , and the I640E mutation may strengthen the dimerization at the C terminus (Figure 4C) . The contact in the mutant transmembrane helices was mostly by interactions of Glu640 and the backbone groups near the C terminus of the partner helix. The I640E dimer is nevertheless similar to the GxxxG-mediated C-terminal dimer in that the C termini of the helices are close to each other.
The JM-A Helix Dimer Is Induced by the N-Terminal Transmembrane Dimer and Is Stabilized by Anionic Lipids It has been previously shown that the juxtamembrane segments linking the transmembrane helices and the kinase domains are critical in EGFR activation (Jura et al., 2009; Red Brewer et al., 2009; Thiel and Carpenter, 2007) . In the active state, the N-terminal portion of the juxtamembrane segments (JM-A) forms antiparallel helix dimers (Scheck et al., 2012; Jura et al., 2009) , and the C-terminal portion (JM-B) interacts with the kinase domains. The JM-A helix dimer thus couples the N-terminal transmembrane dimer at one end with the (active) asymmetric kinase dimer at the other. The new NMR measurements of the TM-JM segments (Endres et al., 2013) identified eight JM-A NOEs, all consistent with an antiparallel helix dimer.
We modeled the active TM-JM-A dimer consisting of an antiparallel JM-A helix dimer attached to an N-terminal transmembrane dimer. The JM-A dimer was so constructed that the hydrophobic sides of the amphipathic JM-A helices were in contact with each other. Notably, simulations of this model showed that the JM-A helices were less stable with DMPC lipids than with POPC/POPS lipids: the JM-A helices melted in three of the four DMPC simulations, and the JM-A dimers fell apart (Figure 5C ). This is consistent with the NMR finding that JM-A helicity is maintained only $30% of the time with DMPC (Endres et al., 2013) . Moreover, when the JM-A helix dimer was maintained, the model satisfied the NOEs remarkably well ( Figure 5A ), although neither the construction of the model nor the simulation used any information from NMR.
It is especially noteworthy that, compared to DMPC, in a POPC/POPS bilayer, the JM-A helices and the helix dimer were better stabilized ( Figure 5C ), and the NOEs were better satisfied throughout the simulation. The JM-A is rich in positively charged basic residues, and the simulation showed that they interacted extensively with the anionic POPS lipids ( Figure S3B ). The stabilizing effect of the POPC/POPS bilayer most likely arose from these electrostatic interactions, which are absent in the neutral DMPC lipids. Additionally, in simulations where the TM-JM dimer was connected to the asymmetric kinase dimer, we observed further stabilization of the JM-A helices (Figure S3F) , suggesting a cooperative interaction between these domains.
The JM-A Segments of Inactive EGFRs Are Embedded in the Membrane
To communicate signals across the membrane, the trans-and juxtamembrane segments presumably adopt distinct conformations in the active or inactive EGFR states. Having argued that an active dimer of EGFR comprises an N-terminal transmembrane dimer and an antiparallel JM-A helix dimer, we now seek to identify the JM-A conformations in a monomeric receptor or an inactive dimer. We first simulated monomeric TM-JM-A. Notably, the JM-A, which was initially placed in solution away from the POPC/POPS membrane, became embedded in the membrane with the JM-A hydrophobic residues buried in the bilayer interior and the basic residues paired with the head groups of the charged lipid ( Figures 5D and S3C) . The membrane embedding of the juxtamembrane segments is consistent with the NMR data of JM-A in detergent micelles (Choowongkomon et al., 2005) . We then performed simulations (with a POPC/POPS bilayer) starting from a C-terminal transmembrane dimer combined with a JM-A dimer. In these simulations, the JM-A dimer either dissociated or significantly deformed ( Figures 5D  and S3A) , suggesting that the C-terminal transmembrane dimer, representative of an inactive state, and the JM-A antiparallel helix dimer, representative of an active state, may not coexist. Structurally, this may be because residues (645-653) connecting the trans-and juxtamembrane segments are rich in positive charges, and when the C-terminal transmembrane dimer brings them close to one another, the resultant repulsion destabilizes the JM-A dimer. By contrast, the N-terminal transmembrane dimer separates these residues and thus stabilizes the JM-A dimer. Taken together, these results support a scenario in which the JM-A conformations alternate between the antiparallel JM-A helix dimer and separated JM-A embedded in the membrane, the former corresponding to the active and the latter to the inactive state.
Assembly of Complete EGFRs
Having characterized the main EGFR components individually, we proceeded to assemble these components into models of near-complete EGFRs (missing the natively unstructured tails C-terminal to the kinase domains). A model of monomeric EGFR ( Figure 6A ; Table S1 ) includes the EGFR extracellular domains adopting a nonextended conformation (Figure 2) , a transmembrane helix, a JM-A embedded in POPC/POPS membrane, and the JM-B connected to the kinase domain (KD) in its inactive kinase conformation (Wood et al., 2004; Jura et al., 2009 ). The kinase domain was placed relative to the membrane so that its two positively charged patches ( Figure 7A ; Lys689, Lys690, Lys692, and Lys715 in one and Arg779, Arg817, Lys851, and Lys889 in the other) were in contact with the membrane and interacting with the anionic lipids. Such an arrangement potentially constitutes another layer of inhibition by occluding the substrate-binding site of the kinase by the membrane ( Figure 7A) .
Similarly, we assembled a model of an EGFR inactive dimer ( Figure 6B ; Table S2 ), which included the simulation-generated, ligand-free extracellular dimer (Figure 3 ), a C-terminal transmembrane dimer, and membrane-embedded JM-A connected S2 and S3 and Tables S1, S2 , and S3 for the coordinates of the structural models.
by the extended JM-B to the (inactive) symmetric kinase dimer (Jura et al., 2009) . The involvement of the symmetric dimer in the inactive dimer of EGFR is consistent with the low-resolution visualization of a globular kinase dimer that differs from the rodlike asymmetric active kinase dimer (Mi et al., 2011) . The symmetric kinase dimer, with the large distance between its (C) A model of overexpression-induced EGFR activation due to reduced availability of the anionic lipids. At normal expression levels (left), extensive interaction with the anionic lipids favors inactive EGFR monomers and dimers over active dimers. At high expression levels (right), a relative scarcity of the anionic lipids leads to EGFR activation. See also Figure S4 . N termini, may be readily connected to a pair of separated juxtamembrane segments embedded in the membrane.
Previously, it has been noted that the positively charged patches of the subunits in the symmetric kinase dimer face the same direction ( Figure 7A ; Jura et al., 2009) . Given that these patches may interact favorably with anionic lipids, in the inactive dimer model we placed the kinase dimer so that these patches faced the membrane. As in the monomer model, here the substrate-binding sites of the kinase domains were again occluded by the membrane ( Figure 7A ).
Our model of the active dimer ( Figure 6C ; Table S3 ) consisted of the two-ligand active extracellular dimer, the N-terminal transmembrane dimer connected with the antiparallel JM-A dimer, and an (active) asymmetric JM-B-KD dimer. The asymmetric kinase dimer (Protein Data Bank [PDB] ID code 2GS6; Zhang et al., 2006) was placed relative to the JM-A dimer according to the orientation seen in the crystal structure of the JM-KD construct (PDB ID code 3GOP; Red Brewer et al., 2009) . Unlike the inactive EGFR dimer, where the substrate-binding sites of the kinase domains are occluded by the membrane, in the active EGFR dimer, the site of the enzymatically activated receiver kinase faces the interior of the cell ( Figure 7A ). Although the key components of EGFR dimers were stable in our simulations of the EGFR models, some flexibility was observed between these components (Figure 6 ; Movies S2 and S3). For instance, the extracellular module of the active dimer may undergo significant motions relative to the transmembrane segments and the membrane but itself maintains a small distance between its C termini ( Figure S1E ). Rather than standing upright on the membrane, the extracellular modules are flexible in orientation and often rest on the membrane surface, in agreement with previous FRET measurements (Kä stner et al., 2009 ).
EGFR Interactions with Anionic Membrane Lipids
Our models highlight the extensive electrostatic interaction between EGFR and the intracellular leaflet of the membrane. Such interaction is reflected in the clustering of anionic POPS lipids around EGFR in our simulations. The simulations show that the EGFR monomer, and inactive and active dimers, respectively, are in contact (within 5 Å ) with 25 ± 3, 52 ± 2, and 37 ± 3 POPS lipid molecules on average (at 15% POPS; see Figures  7A and S4) . In all three cases, the POPS in contact with EGFR accounted for $50% of all the lipids in contact, whereas POPS accounted for only 30% (15% overall for the bilayer) of the inner-leaflet lipids (see Supplemental Information; Figures S4B  and S4C ). We have also observed similar trends in simulations with lower (7.5% and 2.5% of the overall lipid number) POPS content. The JM-A, which is rich in basic residues, interacts extensively with the anionic lipids both in inactive EGFRs, where it is embedded in the membrane, and in the active EGFR dimers, where it is part of an antiparallel helix dimer ( Figure S3 ). As discussed above, such interactions in the active dimer presumably stabilize the JM-A dimer and strengthen the coupling between the extra-and intracellular modules.
We found that inactive EGFR interacted with the anionic lipids more extensively than did active EGFR. For example, on average, $26 POPS molecules were in contact with each receptor in the inactive monomer or dimer, versus $18-19 in the active dimer. This is because, in inactive EGFR, the basic residues of the kinase domains are exposed and in contact with the membrane (Figure 7A ), whereas in the active dimer, the patches are shielded by the C-terminal tails, as shown in the crystal structure (PDB ID code 2GS6; Zhang et al., 2006) .
The interaction of EGFR with anionic lipids thus is likely more energetically favorable for inactive than for active EGFR. If so, the interaction of the membrane with the intracellular portion of EGFR would give a net contribution to EGFR inhibition. This is consistent with our finding that lowering POPS concentration leads to destabilization of the inactive dimer conformation and detachment of the kinase domains from the membrane (Figures 7B and S4D) . Although the C-terminal transmembrane dimer associated with EGFR autoinhibition was stable in the inactive TM-JM-KD dimer at 15% (overall) POPS, it dissociated in simulations with lower POPS content ( Figure 7B ), presumably because the interaction of the anionic lipids with the juxtamembrane segments is needed to stabilize the inactive EGFR dimer. Remarkably, simulations with reduced POPS concentration (0%-2.5%) also show that the kinase domains of the inactive EGFR dimer may detach from the membrane when there is a lack of negatively charged lipids ( Figure 7B ). Such detachment may favor activation, as the intracellular EGFR module has been found to be active in solution but inhibited when attached to the cell membrane (Endres et al., 2013) .
DISCUSSION
The simulation studies and the experimental findings (Endres et al., 2013) together shed light on the overall architecture of intact EGFRs in the membrane environment and on the structural mechanism of autoinhibition and activation. The extracellular module plays an inhibitory role in the absence of ligands, as its deletion leads to ligand-independent activation. Our simulations show that, in addition to impeding receptor dimerization, ligandfree extracellular dimers (especially the two domain IVs) disfavor activation in preformed dimers by assuming conformations inconsistent with the formation of the N-terminal transmembrane dimers. This explains why the insertion of a flexible linker between the extracellular and the transmembrane segments, which presumably decouples the former from the rest of EGFR, causes enhanced activity in the absence of ligands.
In addition, our studies highlight the previously largely overlooked role of the membrane in maintaining the coupling of EGFR extracellular domains with the rest of the receptors. The anionic lipids were found to extensively interact with the basic residues of the juxtamembrane segments, helping stabilize the juxtamembrane helix dimer and, indirectly, the active kinase dimer. These interactions led to a stronger conformational coupling between the trans-and juxtamembrane segments in the POPC/POPS membrane than in the DMPC one, as reflected in the greater stability of the juxtamembrane helix dimer in the former membrane. This may explain why EGFR activity in response to EGF stimulus is reduced at lower levels of anionic PIP2 lipids in the cell membrane (Michailidis et al., 2011) . It is likewise not entirely surprising that, for EGFRs immersed in detergent micelles rather than embedded in a cell membrane, the dimerization of their extracellular modules is not necessarily coupled to the dimerization of their intracellular modules (Mi et al., 2011; Wang et al., 2011) .
While the membrane helps ensure that ligand binding leads to robust EGFR activation, our studies show that it also plays a crucial role in the autoinhibition. The surface of an EGFR kinase domain features extensive patches of basic residues (Jura et al., 2009) , which are shielded by the C-terminal tails only in an active dimer. Our simulations show that inactive EGFR kinases, whether monomers or dimers, attach to the membrane, and the basic residues interact extensively with the anionic lipids. As a result, the active sites of the kinase domains are obstructed. In comparison, the asymmetric kinase dimer in an active EGFR dimer has less interactions with the anionic lipids, and the active site of the enzymatically active ''receiver'' kinase is exposed ( Figure 7A ).
On balance, the anionic lipids of the membrane favor the inactive state of EGFR. This is an important feature of the ''electrostatic engine'' model, in which EGFR activation is postulated to involve the breaking of electrostatic interactions and the release of the intracellular module from the membrane (McLaughlin et al., 2005) . Our observation that the inactive dimer interacts more extensively with the membrane ( Figure 7A ) may be important to EGFR autoinhibition. In normal cells, the effective EGFR concentration on the cell surface can reach 20 mM ($150 molecules per mm À2 in surface density), but the dissociation constant for active dimers of EGFR kinase domains is $6 mM without stabilization by the juxtamembrane segment (Shan et al., 2012) . Since the juxtamembrane domains are long and flexible, these numbers suggest that active kinase domain dimers would form in the absence of ligand stimulation if the formation does not require breaking favorable interactions with the membrane. The important role of anionic lipids in EGFR inhibition led us to speculate that a relative shortage of anionic lipids may underlie the aberrant activity associated with EGFR overexpression that has been observed in many cancer cells. Although overexpression presumably causes an enhanced level of EGFR dimerization, it remains unclear how overexpression overwhelms the autoinhibitory mechanism that ordinarily ensures that ligandfree dimers are inactive. It has been shown (Endres et al., 2013) that, in the absence of ligands, EGFR activity depends on EGFR density at the cell surface. Notably, EGFR activity appears to grow strongly only in the density range beyond 800 mm À2 , suggesting a possible autoinhibitory mechanism that breaks down at high EGFR density. Our analysis shows that a dimerization model with a density-independent dissociation constant of the active dimer fits the data less well than a similar model with a dissociation constant that decreases with higher densities (Figure S4E ). The latter model implies that the active dimer is favored at high densities beyond the effect of high concentration. We conjecture that EGFR overexpression, and a consequent relative shortage of anionic lipids, may weaken the coupling between EGFR extra-and intracellular modules and shift the balance toward active kinase dimers ( Figure 7C ).
EXPERIMENTAL PROCEDURES
The simulations were performed on the special-purpose supercomputer Anton (Shaw et al., 2009 ). The simulated systems ranged in size from $35,000 to $554,000 atoms (Table S4 ). All proteins, water molecules, and membrane lipids were represented in full atomic detail. See the Extended Experimental Procedures for details of the protocols of the MD simulation and system setup and the force fields used in the simulations.
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